Ramesh A. Shivdasani

Author

Also Known As

Andrew L. Kung, NJ Bessman, R A Shivdasani, R. A. Shivdasani, R. Shivdasani, R.A. SHIVDASANI, R.A. Shivdasani, RAMESH A. SHIVDASANI, Ramesh A Shivdasani, Ramesh A. SHIVDASANI

270

Publications

27.4K

Citations

H-Index

162

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Harvard Stem Cell Institute Howard Hughes Medical Institute

About

Ramesh A. Shivdasani is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	75	15.4K
2	Natural Sciences	12	12	1.9K
3	Health Sciences	6	6	1.1K
4	Engineering	4	4	402
5	Public Health	1	1	61

Ramesh A. Shivdasani

147

Publications

24.3K

Citations

H-Index

Page 1

	Year	Citations
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma Aleksandar D. Kostic, Dirk Gevers, Chandra Sekhar Pedamallu, Genome Research Colorectal CarcinomaMicrobiota StructureMicrobial DiversityDysbiosisFusobacterium Sequences	2011	1.9K
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL Ramesh A. Shivdasani, Erica L. Mayer, Stuart H. Orkin Nature Hematological MalignancyBlood FormationMedicineMalignant Blood DisorderHematology	1995	953
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Adam J. Bass, Hideo Watanabe, Craig H. Mermel, Nature Genetics Tumor BiologyOncogenic AgentMedicineAmplified Lineage-survival OncogenePathology	2009	944
Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development Ramesh A. Shivdasani, Margery Rosenblatt, Dorothea Zucker‐Franklin, Cell	1995	697
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity Ron Firestein, Adam J. Bass, So Young Kim, Nature Tumor BiologyOncologyOncogenic AgentMedicineColorectal Cancer	2008	670
A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development Ramesh A. Shivdasani, Yuko Fujiwara, Michael A. McDevitt, The EMBO Journal Transcriptional RegulationCell LineageDevelopmental BiologyGeneticsLineage-selective Knockout	1997	669
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer Mark M. Pomerantz, Nasim Ahmadiyeh, Jia Li, Nature Genetics Tumor BiologyCancer RiskCancer EpidemiologyMedicineColorectal Cancer	2009	661
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Science Translational Medicine Cetuximab SensitivityOncologyErbb2 SignalingSignaling PathwayMedicine	2011	658
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex Maı̈na Lepourcelet, Ying-Nan P. Chen, Dennis S. France, Cancer Cell Signal TransductionSignaling PathwayNatural SciencesMolecular BiologySmall-molecule Antagonists	2004	643
Dynamic Visualization of Thrombopoiesis Within Bone Marrow Tobias Junt, Harald Schulze, Chen Zhao, Science Platelet GenerationDynamic VisualizationBlood CellPathologyBiomedical Engineering	2007	632

Page 1